(Q37756520)

22 August 2017

1 reference

title

Anti-atherogenic effects of resveratrol (English)

1 reference

22 August 2017

1 reference

2

P J H Jones

1 reference

22 August 2017

V R Ramprasath

1

1 reference

22 August 2017

19 May 2010

1 reference

European Journal of Clinical Nutrition

22 August 2017

1 reference

22 August 2017

64

1 reference

22 August 2017

7

1 reference

22 August 2017

660-668

1 reference

https://scigraph.springernature.com/pub.10.1038/ejcn.2010.77

22 August 2017

0 references

cites work

Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Cardiovascular protective effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol-associated renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol in cardioprotection: a therapeutic promise of alternative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Beneficial effects of resveratrol on atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Structure-activity relationship and mechanism of the tocopherol-regenerating activity of resveratrol and its analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Antioxidant effects of resveratrol and its analogues against the free-radical-induced peroxidation of linoleic acid in micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Biological effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Antioxidant vitamins and coronary artery disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol inhibits fatty acid and triacylglycerol synthesis in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Beyond alcohol: beverage consumption and cardiovascular mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Pharmacological preconditioning with resveratrol: role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Toxicogenomics of resveratrol in rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Oxidized LDL and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Interleukin-6 and acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol decreases early signaling events in washed platelets but has little effect on platelet in whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Estrogenic activity in white and red wine extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Inhibition of Cyclic Strain-Induced Endothelin-1 Gene Expression by Resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol modulates apoptosis and oxidation in human blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. Enhancement by calcium flux and concurrent cyclooxygenase-2 up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Inhibitory effect of resveratrol on proteinuria, hypoalbuminemia and hyperlipidemia in nephritic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol and vitamin C as antioxidants in blood platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol: from grapevines to mammalian biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Red Wine Ingredient Resveratrol Protects from β-Amyloid Neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Sequestering ability of butylated hydroxytoluene, propyl gallate, resveratrol, and vitamins C and E against ABTS, DPPH, and hydroxyl free radicals in chemical and biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol: a molecule whose time has come? And gone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

The "French Paradox" and beyond: neuroprotective effects of polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Potential of resveratrol in anticancer and anti-inflammatory therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Resveratrol protects against global cerebral ischemic injury in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Oxidized LDL and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

7 January 2021

Biological effects of resveratrol

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

7 January 2021

Inhibition of human LDL oxidation by resveratrol

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

7 January 2021

The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

7 January 2021

Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

7 January 2021

Antioxidative and prooxidative action of stilbene derivatives

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

7 January 2021

Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of ApoB100 from human HepG2 cells

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

7 January 2021

The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

7 January 2021

Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

7 January 2021

Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

7 January 2021

Is resveratrol an estrogen agonist in growing rats?

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

7 January 2021

Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

7 January 2021

Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.77

7 January 2021

Identifiers

DOI

10.1038/EJCN.2010.77

1 reference

22 August 2017

1 reference

PubMed ID

20485301